07-12-2010 11:07 "Orexigen Therapeutics (OREX) shares are flat in the regular session after the company told a US Food and Drug Administration panel that its Contrave weight-loss drug can help patients lose weight safely, Reuters reported.
- Clarus Therapeutics Expands Executive Team in Preparation for Landmark Launch of JATENZO (testosterone undecanoate) Capsules CIII – GlobeNewswire
- Testosterone Replacement Therapy Market 2019| Key Manufacturers and Development for Global Regions (United States, Europe, Japan, China) Forecast up…
- Testosterone Replacement Therapy Market Global Briefing, Growth Analysis and Outlook 2019 to 2027 – Financial Sector
- Yes, a prosecco diet exisits – here’s everything to know – Now To Love
- Ederra Bella Plastic Surgery and Medical Spa in Johns Creek, Georgia, is Now Offering the Innovative CoolSculpting Procedure for Patients – Yahoo…